insulin requirements , c-peptide levels , and serum lipids have been assessed in 12 obese , insulin-requiring ( greater than 60 u/day ) patients with type ii diabetes mellitus , in a randomized crossover fashion with two treatment regimens : nph alone and combined nph and tolazamide , over a period of 3 months each , with maintenance of weight and glycemic control ( hga1 , 2hpp and mean 24h glucose profile ) at comparable levels .
C0021641
insulin
C0011860
type ii